Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Eisai

Status: Completed

Conditions: Alzheimer's Disease

Treatments: Drug: donepezil hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT01129596

ART05T

Details and patient eligibility

About

The purpose of this study is to investigate the following about donepezil hydrochloride administration in patients with mild or moderate Alzheimer's Disease in clinical practice: cognitive function, Functional Assessment Staging (FAST) score, adverse events/adverse drug reactions, and patient background.

Enrollment: 10,238 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients diagnosed with Alzheimer's Disease by Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Patients diagnosed with mild or moderate Alzheimer's Disease, applicable to FAST score 4 or 5.

Exclusion criteria

Patients with history of hypersensitivity to component of Aricept or piperidine derivative. Patients registered for this survey before.

Trial design

10,238 participants in 1 patient group

1

Treatment:

Drug: donepezil hydrochloride